Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$6.04 - $8.37 $300,188 - $415,988
-49,700 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$5.32 - $8.96 $22,950 - $38,653
-4,314 Reduced 7.99%
49,700 $378,000
Q3 2020

Nov 05, 2020

BUY
$4.78 - $9.06 $4,598 - $8,715
962 Added 1.81%
54,014 $264,000
Q2 2020

Aug 12, 2020

BUY
$6.57 - $8.3 $196,094 - $247,730
29,847 Added 128.62%
53,052 $357,000
Q1 2020

May 12, 2020

SELL
$4.24 - $9.89 $351 - $820
-83 Reduced 0.36%
23,205 $160,000
Q4 2019

Jan 27, 2020

BUY
$4.56 - $8.78 $106,193 - $204,468
23,288 New
23,288 $198,000

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $218M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.